The association between STK11/LKB1 and/or KEAP1 mutations and response to PD-1/PD-L1 inhibitors in patients with advanced non-small cell lung cancer (NSCLC).

被引：0

作者：

Miller, Meagan Elizabeth

Patel, Meera

Althouse, Sandra K.

Hanna, Nasser H.

Mamdani, Hirva

机构：

[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA

[2] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA

[3] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA

[4] Barbara Ann Karmanos Canc Inst, Detroit, MI USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e21538

引用

页数：2

共 50 条

[1] Association of STK11/LKB1 mutations with primary resistance to PD-1/PD-L1 axis blockade in PD-L1 positive nonsquamous NSCLC.
Skoulidis, Ferdinandos
Carter, Brett W.
Zhang, Jianjun
Wistuba, Ignacio Ivan
Papadimitrakopoulou, Vassiliki
Heymach, John
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[2] STK11/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive?
Di Federico, Alessandro
De Giglio, Andrea
Parisi, Claudia
Gelsomino, Francesco
[J]. EUROPEAN JOURNAL OF CANCER, 2021, 157 : 108 - 113
[3] The Efficacy of Immunotherapy and Chemoimmunotherapy in STK11, KEAP1 & KRAS Gene Mutations in Advanced Non-small Cell Lung Cancer (NSCLC)
Cheung, T. W.
Morales, J.
Sacks, H.
Rolfo, C.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S630 - S630
[4] Mutations of the LKB1/STK11 gene in non-small cell lung cancer with loss of heterozygosity
Yang, Sei-Hoon
Meerzaman, Daoud
Mechanic, Leah E.
Gill, Rajbir
Dracheva, Tatiana
Han, Seung-Bum
Kim, Sam-Yong
Bowman, Elise D.
Harris, Curtis C.
Jen, Jin
[J]. ANNALS OF ONCOLOGY, 2006, 17 : 246 - 246
[5] Unraveling the Role of STK11/LKB1 in Non-small Cell Lung Cancer
Sumbly, Vikram
Landry, Ian
[J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
[6] STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma
Skoulidis, Ferdinandos
Goldberg, Michael E.
Greenawalt, Danielle M.
Hellmann, Matthew D.
Awad, Mark M.
Gainor, Justin F.
Schrock, Alexa B.
Hartmaier, Ryan J.
Trabucco, Sally E.
Gay, Laurie
Ali, Siraj M.
Elvin, Julia A.
Singal, Gaurav
Ross, Jeffrey S.
Fabrizio, David
Szabo, Peter M.
Chang, Han
Sasson, Ariella
Srinivasan, Sujaya
Kirov, Stefan
Szustakowski, Joseph
Vitazka, Patrik
Edwards, Robin
Bufill, Jose A.
Sharma, Neelesh
Ou, Sai-Hong I.
Peled, Nir
Spigel, David R.
Rizvi, Hira
Aguilar, Elizabeth Jimenez
Carter, Brett W.
Erasmus, Jeremy
Halpenny, Darragh F.
Plodkowski, Andrew J.
Long, Niamh M.
Nishino, Mizuki
Denning, Warren L.
Galan-Cobo, Ana
Hamdi, Haifa
Hirz, Taghreed
Tong, Pan
Wang, Jing
Rodriguez-Canales, Jaime
Villalobos, Pamela A.
Parra, Edwin R.
Kalhor, Neda
Sholl, Lynette M.
Sauter, Jennifer L.
Jungbluth, Achim A.
Mino-Kenudson, Mari
[J]. CANCER DISCOVERY, 2018, 8 (07) : 822 - 835
[7] Efficacy and safety of PD-1/PD-L1 inhibitors in elderly patients with advanced non-small cell lung cancer
Li, Li
Xu, Chunhua
Wang, Wei
Zhang, Qian
[J]. CLINICAL RESPIRATORY JOURNAL, 2024, 18 (05):
[8] LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value
Facchinetti, Francesco
Bluthgen, Maria Virginia
Tergemina-Clain, Gabrielle
Faivre, Laura
Pignon, Jean-Pierre
Planchard, David
Remon, Jordi
Soria, Jean-Charles
Lacroix, Ludovic
Besse, Benjamin
[J]. LUNG CANCER, 2017, 112 : 62 - 68
[9] Evaluation of Toxicity Profile of PD-1 versus PD-L1 Inhibitors in Non-Small Cell Lung Cancer (NSCLC)
Pillai, Rathi
Behera, Madhusmita
Owonikoko, Taofeek
Kamphorst, Alice
Pakkala, Suchita
Belani, Chandra
Khuri, Fadlo
Ahmed, Rafi
Ramalingam, Suresh
[J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S253 - S254
[10] Evaluation of toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer (NSCLC).
Pillai, Rathi Narayana
Behera, Madhusmita
Owonikoko, Taofeek Kunle
Kamphorst, Alice O.
Pakkala, Suchita
Belani, Chandra Prakash
Khuri, Fadlo Raja
Ahmed, Rafi
Ramalingam, Suresh S.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)

← 1 2 3 4 5 →